Abstract
Background
Foreign body reaction in brain tissue is a very rare immune response that has not been well studied. Hemostatic material has been reported as a possible trigger of this response in other organs and could be detected by [18F]fluorodeoxyglucose positron emission tomography/computerized tomography ([18F]FDG PET/CT), but there is no reported experience about the role of [18F]fluorocholine in this finding. [18F]Fluorocholine has the potential to differentiate viable central nervous system tumors from other entities, so it is frequently used in the follow-up of neurosurgery patients.
Case presentation
A right frontoparietal neoplastic lesion was found in a young-aged patient with analgesic refractory headache. Surgical resection and postsurgical radiotherapy were performed, and the pathologist analysis turned out a cellular ependymoma with signs of anaplasia. In the follow-up, an magnetic resonance imaging (MRI) showed a suspicious lesion, so a [18F]fluorocholine PET/CT was performed. Increased uptake was described in the right parietal region on the margin of the residual cystic lesion. The patient got a complete resection which was confirmed later by MRI. In the pathology analysis, a focally congestive cerebral parenchyma with a central histiocytic reaction to a foreign body area was described.
Conclusions
Following the experience of the current case report, [18F]fluorocholine PET/CT could also show a false positive related to foreign body reaction. This entity should be considered to avoid unnecessary major surgery on our patients.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Instituto de Investigación Biosanitaria Ibs-GRANADA, Granada, Spain (GRID:grid.507088.2); Servicio de Medicina Nuclear, Complejo Hospitalario de Jaén, Jaén, Spain (GRID:grid.418878.a) (ISNI:0000 0004 1771 208X)
2 Instituto de Investigación Biosanitaria Ibs-GRANADA, Granada, Spain (GRID:grid.507088.2); Servicio de Medicina Nuclear, H.U. Virgen de Las Nieves, Granada, Spain (GRID:grid.411380.f) (ISNI:0000 0000 8771 3783)
3 Instituto de Investigación Biosanitaria Ibs-GRANADA, Granada, Spain (GRID:grid.507088.2); Servicio de Radiodiagnóstico, H.U. Virgen de Las Nieves, Granada, Spain (GRID:grid.411380.f) (ISNI:0000 0000 8771 3783)
4 H.U. Virgen de Las Nieves, Servicio de Neurocirugía, Granada, Spain (GRID:grid.411380.f) (ISNI:0000 0000 8771 3783)
5 H.U. Virgen de Las Nieves, Servicio de Anatomía Patológica, Granada, Spain (GRID:grid.411380.f) (ISNI:0000 0000 8771 3783)